Showing results (761-770 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|March 19, 2017
Effects of histone deacetylase inhibitory prodrugs on epigenetic changes and DNA damage response in tumor and heart of glioblastoma xenograftNataly Tarasenko, Abraham Nudelman, Gabriela Rozic, et al.Investigational New Drugs|February 1, 2017
Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapyYuichi Tambo, Yukio Hosomi, Hiroshi Sakai, et al.Investigational New Drugs|July 13, 2019
Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinomaMarcus Noel, Eileen M O'Reilly, Brian M Wolpin, et al.Investigational New Drugs|January 27, 2017
Gemcitabine and S-1 versus gemcitabine and cisplatin treatment in patients with advanced biliary tract cancer: a multicenter retrospective studyNaminatsu Takahara, Hiroyuki Isayama, Yousuke Nakai, et al.Investigational New Drugs|October 19, 2018
Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancerLaura W Goff, Nilofer S Azad, Stacey Stein, et al.Investigational New Drugs|October 16, 2009
A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanomaKarl D Lewis, Wolfram Samlowski, John Ward, et al.Investigational New Drugs|January 1, 1996
A phase II trial of amonafide, caracemide, and homoharringtonine in the treatment of patients with advanced renal cell cancerR S Witte, P Hsieh, P Elson, et al.Investigational New Drugs|February 1, 1993
Phase II trial of 6-thioguanine administered as 120 hour continuous infusion for refractory or recurrent small cell lung cancer. A Southwest Oncology Group studyS K Williamson, J Crowley, R B Livingston, et al.Investigational New Drugs|February 1, 1993
Phase II study of sulofenur (LY 186641). A novel antineoplastic agent in advanced non-small cell lung cancerN C Munshi, D E Seitz, F Fossella, et al.Investigational New Drugs|January 1, 1996
Curative chemotherapy for acute myeloid leukemia: the development of high-dose ara-C from the laboratory to bedsideR L CapizziPageof 372